Tyrosine Kinase Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Other), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Other), By Region, By Competition, 2019-2029F

Published	Pages	Publisher	Report code
Apr 2024	183	TechSci Research	ASDR-663339

Published: Apr 2024 - Pages : 183 - Publisher : TechSci Research - Report code : ASDR-663339

1. AstraZeneca PLC

2. Bayer AG

3. Boehringer Ingelheim International

4. Bristol-Myers Squibb Company

5. Eisai Co. Ltd

6. F. Hoffmann-La Roche Ltd

7. Johnson and Johnson

8. Novartis AG

9. Pfizer Inc.

10. Eli Lilly and Company

Tyrosine Kinase Inhibitors: Global Market Outlook

This report can be of interest as well:

Tyrosine Kinase Inhibitors: Global Market Outlook

Published: November, 2023 | Report code: ASDR-640270